Clinical Trials Logo

Clinical Trial Summary

CAPACITY (www.capacity-covid.eu) is a registry of patients with COVID-19 across Europe and has been established to answer questions on the role of cardiovascular disease in this pandemic. It is an extension of the Case Record Form (CRF) that was released by the ISARIC (International Severe Acute Respiratory and Emerging Infection Consortium) and WHO (World Health Organisation) in response to the emerging outbreak of COVID-19.


Clinical Trial Description

The aim of CAPACITY is to collect data regarding the cardiovascular history, diagnostic information and occurrence of cardiovascular complications in COVID-19 patients. By collecting this information in a standardized manner, CAPACITY can aid in providing more insight in (1) the incidence of cardiovascular complications in patients with COVID-19, and (2) the vulnerability and clinical course of COVID-19 in patients with an underlying cardiovascular disease. The CAPACITY extension to the ISARIC-WHO CRF consists of additional data collection instruments for: - cardiac history and cardiovascular risk factors - prior use of cardiac medication or NSAIDs - electrocardiography (ECG) - echocardiography - cardiac MRI - invasive cardiac procedures - cardiac complications - cardiac biomarkers - cardiac outcome during admission ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04325412
Study type Observational [Patient Registry]
Source UMC Utrecht
Contact Folkert W. Asselbergs, MD, PhD
Phone +31 (0) 88 755 5555
Email f.w.asselbergs@umcutrecht.nl
Status Recruiting
Phase
Start date March 23, 2020
Completion date June 23, 2021